Seizures as treatment-emergent adverse events during glioblastoma clinical trials.

被引：0
|
作者：
Dillman, Robert O. [1 ]
机构：
[1] AIVITA Biomed, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14018
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis
    Camporeale, Angelo
    Day, Kathleen Ann
    Ruff, Dustin
    Arsenault, Jody
    Williams, David
    Kelsey, Douglas K.
    DRUG SAFETY, 2013, 36 (08) : 663 - 671
  • [22] Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis
    Angelo Camporeale
    Kathleen Ann Day
    Dustin Ruff
    Jody Arsenault
    David Williams
    Douglas K. Kelsey
    Drug Safety, 2013, 36 : 663 - 671
  • [23] Characterization of Dizziness Treatment-Emergent Adverse Events After Lasmiditan: Findings of the SAMURAI and SPARTAN Phase 3 Acute Migraine Treatment Trials
    Tepper, S. J.
    Krege, J.
    Day, K.
    Lombard, L.
    Jia, N.
    Wietecha, L.
    Friedman, D., I
    HEADACHE, 2018, 58 : 172 - 173
  • [24] Prucalopride: factors associated with treatment-emergent adverse events in Asian and non-Asians
    Leelakusolvong, Somchai
    Ke, Meiyun
    Duowu, Zou
    Choi, Suck Chei
    Tack, Jan
    Quigley, Eamonn
    Liu, Andy
    Kim, Jinyong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 352 - 352
  • [25] Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis
    Wang, Jacqueline F.
    Hwang, Steven R.
    Jiang, Yi
    Qi, Xinyue
    Zhang, Shijia
    Parikh, Sameer A.
    Ding, Wei
    Kenderian, Saad S.
    Muchtar, Eli
    Hampel, Paul J.
    Leis, Jose F.
    Munoz, Javier L.
    Thanarajasingam, Gita
    Paludo, Jonas
    Inwards, David J.
    Nowakowski, Grzegorz S.
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Kay, Neil E.
    Zhou, Shouhao
    Wang, Yucai
    BLOOD, 2022, 140 : 9882 - 9884
  • [26] Treatment-Emergent Adverse Events (TEAEs) by Age for Patients with Lennox-Gastaut Syndrome (LGS) Treated with Clobazam during Phase II/III Trials
    Isojarvi, Jouko
    Lee, Deborah
    Buchhalter, Jeffrey
    NEUROLOGY, 2013, 80
  • [27] A new method to analyze adverse events longitudinally in oncology clinical trials.
    Thanarajasingam, Gita
    Novotny, Paul J.
    Loprinzi, Charles L.
    Grothey, Axel
    Atherton, Pamela J.
    Sloan, Jeff A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
    Labadie, Brian W.
    Morris, David S.
    Bryce, Alan H.
    Given, Robert
    Zhang, Jingsong
    Abida, Wassim
    Chowdhury, Simon
    Patnaik, Akash
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 673 - 686
  • [29] Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications
    Cavazzoni, P
    Mukhopadhyay, N
    Carlson, C
    Breier, A
    Buse, J
    BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : S94 - S101
  • [30] Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials
    Cavazzoni, PA
    Berg, PH
    Kryzhanovskaya, LA
    Briggs, SD
    Roddy, TE
    Tohen, M
    Kane, JM
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 107 - 113
12345